Shares of Hikma Pharmaceuticals PLC (OTCMKTS:HKMPY – Get Free Report) were down 2.1% during trading on Thursday . The stock traded as low as $58.00 and last traded at $58.00. Approximately 375 shares traded hands during mid-day trading, a decline of 55% from the average daily volume of 826 shares. The stock had previously closed at $59.26.
Hikma Pharmaceuticals Price Performance
The firm’s 50-day moving average is $53.05 and its 200 day moving average is $51.36.
About Hikma Pharmaceuticals
Hikma Pharmaceuticals PLC develops, manufactures, markets, and sells a range of generic, branded, and in-licensed pharmaceutical products. It operates through three segments: Injectables, Generics, and Branded. The Injectables segment provides generic injectable products primarily for use in hospitals.
Further Reading
- Five stocks we like better than Hikma Pharmaceuticals
- Market Cap Calculator: How to Calculate Market Cap
- Unity Stock: Is a True Turnaround Finally Taking Shape?
- Low PE Growth Stocks: Unlocking Investment Opportunities
- DuPont’s Electronics Spinoff: The Start of Something Big
- Quiet Period Expirations Explained
- The Trade Desk Crashes on Earnings, But Growth Catalysts Persist
Receive News & Ratings for Hikma Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hikma Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
